Radiant Biotherapeutics Funding: $45M Raised, Series A
Radiant Biotherapeutics is based in Toronto, Canada. It has raised $45M in total funding. Latest round: Series A.
Radiant Biotherapeutics funding overview
Radiant Biotherapeutics is based in Toronto, Canada. Radiant Biotherapeutics has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for Radiant Biotherapeutics runs through 2024; nothing later has been disclosed. Investors on record include Amplitude Ventures, Bill & Melinda Gates Foundation. 2 distinct backers are named across the disclosed rounds.
Radiant Biotherapeutics at a glance
Total raised
$45M
Latest round
Series A
Latest round date
September 2024
Headquarters
Toronto, Canada
Notable investors
Amplitude Ventures, Bill & Melinda Gates Foundation
Frequently asked about Radiant Biotherapeutics funding
How much has Radiant Biotherapeutics raised?
Radiant Biotherapeutics has raised $45M in total disclosed funding across the rounds on record.
Who has invested in Radiant Biotherapeutics?
Amplitude Ventures, Bill & Melinda Gates Foundation are named among the investors backing Radiant Biotherapeutics.
What was the latest Radiant Biotherapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2024.
Where is Radiant Biotherapeutics based?
Radiant Biotherapeutics is based in Toronto, Canada.
When did Radiant Biotherapeutics last raise?
The last disclosed Radiant Biotherapeutics round closed in September 2024 at Series A.
We update the Radiant Biotherapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Toronto and their backers are listed below.
